Is it time for in silico simulation of drug cardiac side effects?
Cardiac simulation is used to integrate information on drug action to predict side effects on the whole heart. Could simulation begin to replace animal models?
Main Authors: | Mirams, G, Noble, D |
---|---|
Format: | Journal article |
Published: |
2011
|
Similar Items
-
Is it time for in silico simulation of drug cardiac side effects?
by: Mirams, G, et al.
Published: (2011) -
Novel approaches to assessing cardiac safety−proceedings of a workshop: regulators‚ industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs.
by: Fletcher, K, et al.
Published: (2011) -
Novel approaches to assessing cardiac safety--proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs.
by: Fletcher, K, et al.
Published: (2011) -
Novel approaches to assessing cardiac safety–proceedings of a workshop: regulators‚ industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs
by: Fletcher, K, et al.
Published: (2011) -
Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
by: Mirams, G, et al.
Published: (2012)